NeuroGlove PD Study Clinical
Completed · Early Phase 1
Conditions studied: Parkinson Disease
In brief
Safety and Feasibility of Peripheral Sensory Stimulation of the Hand in the Treatment of Parkinson's Disease
Key facts
- Study ID
- NCT06578273
- Run by
- NeuroGlove LLC
- People needed
- 8
- Starts
- 2024-08-22
- Expected to finish
- 2024-08-22
- Last updated by the study team
- 2024-09-03
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Able to and willing to provide informed consent. Legally authorized representatives (LARs) will not be allowed to consent on behalf of the subject.
- Men and women ≥18 and <85 years of age.
- Carry an active diagnosis of PD
- Suffer from PD symptoms that impact subject's daily activities and quality of life
You may not qualify if…
- Physical limitations of the upper extremity (e.g., fracture, joint deformity, severe spasticity/contracture, wounds, skin breakdown, lymphedema, etc.)
- Lacks the ability to comprehend or follow instructions, or for any reason, in the opinion of the investigator, would be unlikely or unable to comply with study protocol requirements.
- Currently participating in another interventional clinical trial (observational clinical trial participation is allowed for study enrollment.)
Where it is running
- NeuroGlove — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.